Brown Laura J LJ

Show results for

Unknown (16)
Metabolomics (1)
Proteomics (1)

Organisms

Canis lupus familiaris (1)
Homo sapiens (1)
Macaca fascicularis (1)
Mus musculus (1)
Rattus norvegicus (1)

Repository

MetaboLights (1)
PanoramaPublic (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2021 (2)

CHEBI ID

CHEBI:170073 (1)
CHEBI:170071 (1)
CHEBI:170070 (1)
CHEBI:166572 (1)
CHEBI:170067 (1)
CHEBI:134926 (1)
CHEBI:170061 (1)
CHEBI:172382 (1)
CHEBI:170060 (1)
CHEBI:172381 (1)
CHEBI:170058 (1)
CHEBI:170057 (1)
CHEBI:170056 (1)
CHEBI:170055 (1)
CHEBI:170054 (1)
CHEBI:170053 (1)
CHEBI:170052 (1)
CHEBI:170051 (1)
CHEBI:170049 (1)
CHEBI:170048 (1)
CHEBI:170047 (1)
CHEBI:170046 (1)
CHEBI:170044 (1)
CHEBI:170043 (1)
CHEBI:170042 (1)
CHEBI:170041 (1)
CHEBI:91519 (1)
CHEBI:170040 (1)
CHEBI:170039 (1)
CHEBI:172379 (1)

Metabolite Name

Octadecanoicacid (1)
Perfluoroctanoic acid (PFOA) (1)
Hexadecanoicacid (1)
2-(Acetylamino)hexanoic acid (1)
Xylenesulfonate (1)
N1-(4-butyl-2-methylphenyl)-2-(benzylamino)-2-thioxoacetamide (1)
2-Hydroxy-4-methylthiobutanoic acid (1)
DL-Lactic Acid (1)
2-Keto-4-methylthiobutyric acid (1)
N-(1H-benzo[d]imidazol-2-yl)guanidine (1)
2-Hydroxy glutaric acid (1)
2'-Deoxycytidine 5'-monophosphate (dCMP) (1)
Bis(3,5,5-trimethylhexyl) phthalate (1)
Benazol P (1)
(1R,3R,4S,5R)-3,4-bis({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1,5-dihydroxycyclohexane-1-carboxylic acid (1)
2-Heptyl-4-hydroxyquinoline-N-oxide (1)
D-(+)-Camphor (1)
2-({2-[4-(4-Fluorophenyl)piperazino]-2-oxoethyl}sulfanyl)acetic acid (1)
3-Desoxy-3,4-methylenedioxy pyrovalerone (1)
3,5-di-tert-Butyl-4-hydroxybenzaldehyde (1)
(+/-)-threo-Methylnaphthidate (1)
4-Ethoxy ethylbenzoate (1)
6-(2-chloroanilino)-4-oxo-2-(4-pyridyl)-3,4-dihydro-2H-1,3-thiazine-5-carbonitrile (1)
7,7-dimethyl-3-spiro(4,4,-dimethyl-2,6-dioxocyclohexyl)-1,2,3,4,5,6,7,8-octahydro-5-quinolinone (1)
Isobutyl benzoate (1)
2-(4-Methoxybenzylidene)quinuclidin-3-one (1)
2-benzyl-6-hydroxy-2-azabicyclo[2.2.2]octan-3-one (1)
N1-bicyclo[2.2.2]oct-2-ylbenzamide (1)
1-(Benzylamino)-3-(3,4-dimethylphenoxy)propan-2-ol (1)
Imidazosagatriazinone (1)

Release Date

2022 (5)
2024 (3)
2023 (3)
2021 (3)
2025 (2)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Untargeted metabolomics reveals species-specific metabolite production and shared nutrient consumption by Pseudomonas aeruginosa and Staphylococcus aureus

While bacterial metabolism is known to impact antibiotic efficacy and virulence, the metabolic capacities of individual microbes in cystic fibrosis lung infections are difficult to disentangle from sputum samples. Here, we show that untargeted metabolomic profiling of supernatants of multiple str...

2021-05-26 | MTBLS2105 | MetaboLights

Highly multiplexed kinase profiling in spleen with targeted mass spectrometry reveals kinome plasticity across species

Early attrition of drug candidates, including kinase inhibitors, often occurs due to issues that arise during preclinical safety and efficacy evaluation. This problem may be exacerbated by the fact that these studies might fail to consider the basic physiological differences which could exist betwee...

ORGANISM(S): Homo Sapiens Rattus Norvegicus Mus Musculus Canis Lupus Familiaris Macaca Fascicularis

2021-08-19 | PXD024650 | panorama

Point of care tobacco treatment sustains during COVID-19, a global pandemic.

Not available

S-EPMC8854443 | biostudies-literature

Stratified analyses refine association between TLR7 rare variants and severe COVID-19.

Not available

S-EPMC11320601 | biostudies-literature

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

Not available

S-EPMC9333998 | biostudies-literature

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.